Dabur India units face lawsuits in US, Canada alleging products caused
cancer
Send a link to a friend
[October 19, 2023]
(Reuters) -Dabur India said on Wednesday its subsidiaries were
among companies sued in the U.S. and Canada by customers alleging that
the use of hair relaxer products had caused ovarian cancer, uterine
cancer and other health issues.
Shares of the company fell as much as 2.5% on Thursday morning. They
were last down 1.7% at 525 rupees as of 12:06 p.m. IST, extending their
year-to-date decline to 6.5%.
"Currently, the cases are in the pleadings and early discovery phases of
litigation," it said in an exchange filing late on Wednesday, adding the
allegations are based on "unsubstantiated and incomplete" study.
The consumer goods firm said about 5,400 cases against several companies
including its subsidiaries, Namaste Laboratories, Dermoviva Skin
Essentials and Dabur International, have been consolidated as a
multi-district litigation before a U.S. District Court in Illinois.
[to top of second column]
|
![](http://archives.lincolndailynews.com/2023/Oct/19/images/ads/current/graue_lda_PPP_2023.png) The units have denied liability and
have retained counsel to defend them, the company said.
Dabur India, which sells Vatika Shampoo and Honitus
cough syrup brands, said it could not determine the financial
implication due to settlement or verdict outcome at this stage but
expected the defense costs to breach the materiality threshold in
the near future.
The company did not immediately respond to a request for additional
details outside of normal business hours.
(Reporting by Kanjyik Ghosh in Bengaluru; Editing by Sriraj
Kalluvila)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |